Amicus Therapeutics, Inc.Amicus Therapeutics, Inc.Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc.

No trades
See on Supercharts

FOLD fundamentals

Amicus Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of FOLD for the last quarter is 115.08 M USD, and it's 11.19% higher compared to the previous quarter. The net income of Q4 23 is -33.84 M USD.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth